A citation-based method for searching scientific literature

E J Stanek, C L Sanders, K A Johansen Taber, M Khalid, A Patel, R R Verbrugge, B C Agatep, R E Aubert, R S Epstein, F W Frueh. Clin Pharmacol Ther 2012
Times Cited: 266







List of co-cited articles
609 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Primary care physicians' knowledge of and experience with pharmacogenetic testing.
S B Haga, W Burke, G S Ginsburg, R Mills, R Agans. Clin Genet 2012
158
38

Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.
Henry M Dunnenberger, Kristine R Crews, James M Hoffman, Kelly E Caudle, Ulrich Broeckel, Scott C Howard, Robert J Hunkler, Teri E Klein, William E Evans, Mary V Relling. Annu Rev Pharmacol Toxicol 2015
256
27


Pharmacogenomics in the clinic.
Mary V Relling, William E Evans. Nature 2015
355
22

Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.
C H van der Wouden, A Cambon-Thomsen, E Cecchin, K C Cheung, C L Dávila-Fajardo, V H Deneer, V Dolžan, M Ingelman-Sundberg, S Jönsson, M O Karlsson,[...]. Clin Pharmacol Ther 2017
127
19

Pharmacogenetics: from bench to byte--an update of guidelines.
J J Swen, M Nijenhuis, A de Boer, L Grandia, A H Maitland-van der Zee, H Mulder, G A P J M Rongen, R H N van Schaik, T Schalekamp, D J Touw,[...]. Clin Pharmacol Ther 2011
576
18

Pharmacogenomic knowledge gaps and educational resource needs among physicians in selected specialties.
Katherine A Johansen Taber, Barry D Dickinson. Pharmgenomics Pers Med 2014
73
21

Assessment of the pharmacogenomics educational needs of pharmacists.
Kristen B McCullough, Christine M Formea, Kevin D Berg, Julianna A Burzynski, Julie L Cunningham, Narith N Ou, Maria I Rudis, Joanna L Stollings, Wayne T Nicholson. Am J Pharm Educ 2011
114
16

Pharmacogenomics knowledge for personalized medicine.
M Whirl-Carrillo, E M McDonagh, J M Hebert, L Gong, K Sangkuhl, C F Thorn, R B Altman, T E Klein. Clin Pharmacol Ther 2012
900
15

Attitudes of clinicians following large-scale pharmacogenomics implementation.
J F Peterson, J R Field, Y Shi, J S Schildcrout, J C Denny, T L McGregor, S L Van Driest, J M Pulley, I M Lubin, M Laposata,[...]. Pharmacogenomics J 2016
47
29



Educational strategies to enable expansion of pharmacogenomics-based care.
Kristin Wiisanen Weitzel, Christina L Aquilante, Samuel Johnson, David F Kisor, Philip E Empey. Am J Health Syst Pharm 2016
48
25

Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group.
P C D Bank, K E Caudle, J J Swen, R S Gammal, M Whirl-Carrillo, T E Klein, M V Relling, H-J Guchelaar. Clin Pharmacol Ther 2018
98
12

An evaluation of pharmacists' expectations towards pharmacogenomics.
Simon de Denus, Nathalie Letarte, Thierry Hurlimann, Jean-Philippe Lambert, Annie Lavoie, Laura Robb, Nancy L Sheehan, Jacques Turgeon, Barbara Vadnais. Pharmacogenomics 2013
53
22

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.
J K Hicks, K Sangkuhl, J J Swen, V L Ellingrod, D J Müller, K Shimoda, J R Bishop, E D Kharasch, T C Skaar, A Gaedigk,[...]. Clin Pharmacol Ther 2017
206
11

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.
J K Hicks, J R Bishop, K Sangkuhl, D J Müller, Y Ji, S G Leckband, J S Leeder, R L Graham, D L Chiulli, A LLerena,[...]. Clin Pharmacol Ther 2015
401
11

PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics.
James M Hoffman, Cyrine E Haidar, Mark R Wilkinson, Kristine R Crews, Donald K Baker, Nancy M Kornegay, Wenjian Yang, Ching-Hon Pui, Ulrike M Reiss, Aditya H Gaur,[...]. Am J Med Genet C Semin Med Genet 2014
149
11

Pharmacogenomics in the curricula of colleges and schools of pharmacy in the United States.
John E Murphy, James S Green, Laura A Adams, Robert B Squire, Grace M Kuo, Alan McKay. Am J Pharm Educ 2010
86
12

Pharmacogenomics instruction in US and Canadian medical schools: implications for personalized medicine.
James S Green, Travis J O'Brien, Vincent A Chiappinelli, Arthur F Harralson. Pharmacogenomics 2010
53
20

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems.
J A Luzum, R E Pakyz, A R Elsey, C E Haidar, J F Peterson, M Whirl-Carrillo, S K Handelman, K Palmer, J M Pulley, M Beller,[...]. Clin Pharmacol Ther 2017
76
14


Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.
P H O'Donnell, N Wadhwa, K Danahey, B A Borden, S M Lee, J P Hall, C Klammer, S Hussain, M Siegler, M J Sorrentino,[...]. Clin Pharmacol Ther 2017
45
22

Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol.
Suzette J Bielinski, Janet E Olson, Jyotishman Pathak, Richard M Weinshilboum, Liewei Wang, Kelly J Lyke, Euijung Ryu, Paul V Targonski, Michael D Van Norstrand, Matthew A Hathcock,[...]. Mayo Clin Proc 2014
183
10

Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing.
S L Van Driest, Y Shi, E A Bowton, J S Schildcrout, J F Peterson, J Pulley, J C Denny, D M Roden. Clin Pharmacol Ther 2014
164
10

Physicians' preparedness for integration of genomic and pharmacogenetic testing into practice within a major healthcare system.
Christina G Selkirk, Scott M Weissman, Andy Anderson, Peter J Hulick. Genet Test Mol Biomarkers 2013
80
12


Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?
M Verbelen, M E Weale, C M Lewis. Pharmacogenomics J 2017
91
10

Physician-Reported Benefits and Barriers to Clinical Implementation of Genomic Medicine: A Multi-Site IGNITE-Network Survey.
Aniwaa Owusu Obeng, Kezhen Fei, Kenneth D Levy, Amanda R Elsey, Toni I Pollin, Andrea H Ramirez, Kristin W Weitzel, Carol R Horowitz. J Pers Med 2018
56
17

Attitudes and practices among internists concerning genetic testing.
Robert Klitzman, Wendy Chung, Karen Marder, Anita Shanmugham, Lisa J Chin, Meredith Stark, Cheng-Shiun Leu, Paul S Appelbaum. J Genet Couns 2013
105
9

Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project.
J M Pulley, J C Denny, J F Peterson, G R Bernard, C L Vnencak-Jones, A H Ramirez, J T Delaney, E Bowton, K Brothers, K Johnson,[...]. Clin Pharmacol Ther 2012
266
9

Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC).
Kelly E Caudle, Henry M Dunnenberger, Robert R Freimuth, Josh F Peterson, Jonathan D Burlison, Michelle Whirl-Carrillo, Stuart A Scott, Heidi L Rehm, Marc S Williams, Teri E Klein,[...]. Genet Med 2017
207
9

Physicians' opinions following pharmacogenetic testing for psychotropic medication.
Lucas M Walden, Eva J Brandl, Amtul Changasi, Jessica E Sturgess, Alexander Soibel, Janna Fe D Notario, Sheraz Cheema, Nicole Braganza, Victoria S Marshe, Natalie Freeman,[...]. Psychiatry Res 2015
27
33

Pharmacogenetics: from bench to byte.
J J Swen, I Wilting, A L de Goede, L Grandia, H Mulder, D J Touw, A de Boer, J M H Conemans, T C G Egberts, O H Klungel,[...]. Clin Pharmacol Ther 2008
146
9

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update.
J A Johnson, K E Caudle, L Gong, M Whirl-Carrillo, C M Stein, S A Scott, M T Lee, B F Gage, S E Kimmel, M A Perera,[...]. Clin Pharmacol Ther 2017
238
9

Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems.
L J Rasmussen-Torvik, S C Stallings, A S Gordon, B Almoguera, M A Basford, S J Bielinski, A Brautbar, M H Brilliant, D S Carrell, J J Connolly,[...]. Clin Pharmacol Ther 2014
144
9

HLA-B*5701 screening for hypersensitivity to abacavir.
Simon Mallal, Elizabeth Phillips, Giampiero Carosi, Jean-Michel Molina, Cassy Workman, Janez Tomazic, Eva Jägel-Guedes, Sorin Rugina, Oleg Kozyrev, Juan Flores Cid,[...]. N Engl J Med 2008
9

Research Directions in the Clinical Implementation of Pharmacogenomics: An Overview of US Programs and Projects.
Simona Volpi, Carol J Bult, Rex L Chisholm, Patricia A Deverka, Geoffrey S Ginsburg, Howard J Jacob, Melpomeni Kasapi, Howard L McLeod, Dan M Roden, Marc S Williams,[...]. Clin Pharmacol Ther 2018
54
16

Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update.
S A Scott, K Sangkuhl, C M Stein, J-S Hulot, J L Mega, D M Roden, T E Klein, M S Sabatine, J A Johnson, A R Shuldiner. Clin Pharmacol Ther 2013
536
8

Community pharmacists' attitudes towards clinical utility and ethical implications of pharmacogenetic testing.
Sony Tuteja, Kevin Haynes, Cara Zayac, Jon E Sprague, Barbara Bernhardt, Reed Pyeritz. Per Med 2013
41
19

Emerging roles for pharmacists in clinical implementation of pharmacogenomics.
Aniwaa Owusu-Obeng, Kristin W Weitzel, Randy C Hatton, Benjamin J Staley, Jennifer Ashton, Rhonda M Cooper-Dehoff, Julie A Johnson. Pharmacotherapy 2014
77
10

Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program.
R P McKillip, B A Borden, P Galecki, S A Ham, L Patrick-Miller, J P Hall, S Hussain, K Danahey, M Siegler, M J Sorrentino,[...]. Clin Pharmacol Ther 2017
15
53

Implementing genomic medicine in the clinic: the future is here.
Teri A Manolio, Rex L Chisholm, Brad Ozenberger, Dan M Roden, Marc S Williams, Richard Wilson, David Bick, Erwin P Bottinger, Murray H Brilliant, Charis Eng,[...]. Genet Med 2013
335
8

A randomized trial of genotype-guided dosing of warfarin.
Munir Pirmohamed, Girvan Burnside, Niclas Eriksson, Andrea L Jorgensen, Cheng Hock Toh, Toby Nicholson, Patrick Kesteven, Christina Christersson, Bengt Wahlström, Christina Stafberg,[...]. N Engl J Med 2013
539
8

Comparison of delivery strategies for pharmacogenetic testing services.
Susanne B Haga, Jivan Moaddeb. Pharmacogenet Genomics 2014
31
25

Survey of US public attitudes toward pharmacogenetic testing.
S B Haga, J M O'Daniel, G M Tindall, I R Lipkus, R Agans. Pharmacogenomics J 2012
95
8

Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update.
Elizabeth J Phillips, Chonlaphat Sukasem, Michelle Whirl-Carrillo, Daniel J Müller, Henry M Dunnenberger, Wasun Chantratita, Barry Goldspiel, Yuan-Tsong Chen, Bruce C Carleton, Alfred L George,[...]. Clin Pharmacol Ther 2018
96
8

Clinician Perspectives on Using Pharmacogenomics in Clinical Practice.
Kim M Unertl, Habiba Jaffa, Julie R Field, Lisa Price, Josh F Peterson. Per Med 2015
39
20

Implementing pharmacogenomics decision support across seven European countries: The Ubiquitous Pharmacogenomics (U-PGx) project.
Kathrin Blagec, Rudolf Koopmann, Mandy Crommentuijn-van Rhenen, Inge Holsappel, Cathelijne H van der Wouden, Lidija Konta, Hong Xu, Daniela Steinberger, Enrico Just, Jesse J Swen,[...]. J Am Med Inform Assoc 2018
28
28

Primary care physician experiences with integrated pharmacogenomic testing in a community health system.
Amy A Lemke, Christina G Hutten Selkirk, Nicole S Glaser, Annette W Sereika, Dyson T Wake, Peter J Hulick, Henry M Dunnenberger. Per Med 2017
25
32


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.